procollagen C-protease inhibitors (Roche)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug Nameprocollagen C-protease inhibitors (Roche)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionProtease inhibitors
TargetsProtease
Therapy Area/IndicationsInflammationFibrosisRespiratory Distress Syndrome, Adult
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesRoche Palo Alto Llc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesRoche Palo Alto Llc
Active IndicationsN/A
Inactive IndicationsInflammationFibrosisRespiratory Distress Syndrome, Adult

Other Information

ATC CodeN/A
Related LinksN/A